Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Allele Biotechnology Pharmaceuticals" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Allele Biotechnology Pharmaceuticals for you to read. Along with our medical data and news we also list Allele Biotechnology Pharmaceuticals Clinical Trials, which are updated daily. BioPortfolio also has a large database of Allele Biotechnology Pharmaceuticals Companies for you to search.
Allele Biotechnology and Pharmaceuticals has secured grant from the US National Institutes of Health (NIH) unit National Institute of General...Read More... The post Allele Biotechnology gets NIH grant to develop sepsis therapies appeared first on Pharmaceutical Technology.
The National Institute of General Medical Sciences, part of the National Institutes of Health, awarded Allele Biotechnology and Pharmaceuticals a Small Business Innovative Research grant to develop therapies for sepsis.
Scientist.com, the world's leading marketplace for outsourced scientific services, and Allele Biotechnology & Pharmaceuticals Inc., a leading San Diego-based preclinical-stage biopharmaceutical company, have partnered to develop nanoantibodies for therapeutic applications.
NIH Awards Grant to Battle Sepsis to San Diego's Allele Biotechnology and Pharmaceuticals http://dlvr.it/QnPW91 pic.twitter.com/GxCJh3nS7U
Allele uses experts from Scientist.com’s Genius Consulting NetworkTM and proprietary internal technology to create innovative biologics programs Scientist.com, the world's leading marketplace for outsourced scientific services, and Allele Biotechnology & Pharmaceuticals Inc., a leading San Diego-based preclinical-stage biopharmaceutical company, ...
Allele Biotechnology & Pharmaceuticals Inc. has received issuance notices from the U.S. Patent and Trademark Office for its first batch of patents covering the derivation of induced pluripotent stem cells (iPSCs). Allele’s proprietary technology uses only messenger RNA (mRNA) to reprogram human or other primate cells, avoiding many operational compli...
The National Institute of General Medical Sciences of NIH has awarded a Small Business Innovative Research grant to Allele Biotechnology and Pharmaceuticals to develop new single-domain nanoantibody (nAb) therapies for the treatment of sepsis. Sepsis and septic shock are among the leading causes of death in intensive care units (ICUs). The global incidence...
NEW YORK, Nov. 09, 2018 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (Nasdaq:SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications, today announced data from a preplanned secondary efficacy analysis across human leukocyte antigen (HLA) allele subgroups from...
AMAG Pharmaceuticals said today it has agreed to acquire Perosphere Pharmaceuticals for up to $415 million, in a deal that the buyer said will expand its pipeline, and especially its presence in hematology with Perosphere’s next-generation anticoagulant reversal candidate ciraparantag (PER977). Ciraparantag is an intravenously-administered synthetic small molecule anticoagulant reversal agen...
Conatus Pharmaceuticals, Upcoming Presentations, Analysts Review and Target Traders News Source, a leading independent equity research, and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Conatus Pharmaceuticals Inc. (CNAT), a biotechnology company, focused on the development and commercialization of novel medicines for the treatment of liv...
(MedPage Today) -- Effect seen in systemically treated patients with specific APOE allele
(MedPage Today) -- African-Americans with the APOE-e4 allele have lower tau levels in CSF than whites
HENDERSON, Nev.--(BUSINESS WIRE)--Oct. 23, 2018-- Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today...
vTv Therapeutics, Trevena, Cyclacel Pharmaceuticals, Paratek Pharmaceuticals and Avadel Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index. The post 5 Top Weekly NASDAQ Biotech Stocks: vTv Leads with 374 Percent appeared first on Investing News Network.
Genocea Biosciences, EyePoint Pharmaceuticals, Trevena, Adamis Pharmaceuticals and KalVista Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index. The post 5 Top Weekly NASDAQ Biotech Stocks: Genocea Up 56.74 Percent appeared first on Investing News Network.
Telix Pharmaceuticals Limited has acquired Atlab Pharma SAS for $10m. Based in Australia, Telix is a clinical-stage biotechnology company engaged...Read More... The post M&As this week: Telix Pharmaceuticals, PCI Pharma, DZS Clinical Services appeared first on Drug Development Technology.
Vir Biotechnology, Inc. and Alnylam Pharmaceuticals, Inc. (ALNY) said Monday that they have initiated a Phase 1/2 study of VIR-2218, a novel, investigational RNA interference or RNAi therapeutic for the treatment of chronic hepatitis B virus or HBV infection.
SELLAS Life Sciences Announces Additional Data Showing Consistent Clinical Effect Across HLA Allele Subgroups in Triple Negative Breast Cancer (TNBC) Patients Treated with Nelipepimut-S Plus Trastuzumab Presented at the Society for Immunotherapy of Cancer
Final data from Phase 2b clinical trial of nelipepimut-S (NeuVax™) in combination with trastuzumab (Herceptin®) were previously presented at the European Society for Medical Oncology (ESMO) 2018 Annual Meeting Clinically meaningful and statistically significant benefit in the HLA-A24+ subgroup (p=0.003), highly prevalent in the Asian population, with a 90.6% decrease in the relative risk of ...
WATERTOWN, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals (NASDAQ: EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced that it has been selected for addition to the NASDAQ Biotechnology Index® (NASDAQ: NBI). EyePoint’s addition to the NBI will become effective prior to market open on Mo...
WASHINGTON (dpa-AFX) - Vir Biotechnology, Inc. and Alnylam Pharmaceuticals, Inc. (ALNY) said Monday that they have initiated a Phase 1/2 study of VIR-2218, a novel, investigational RNA interferenc...
Rocket Pharmaceuticals, Inc. (Nasdaq: RCKT) (“Rocket”), a leading U.S.-based multi-platform gene therapy company, today announces that the Company has been selected for addition to the NASDAQ Biotechnology Index® (NASDAQ: NBI). Rocket’s addition to the NBI will become effective prior to market open on Monday, December 24, 2018. The N...
CAMBRIDGE, MA – December 1, 2018 – X4 Pharmaceuticals, a clinical stage biotechnology company developing novel CXCR4 allosteric antagonist drugs to improve immune cell trafficking to treat rare diseases and cancer, today announced the...